External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas

Four potential biomarkers as prognostic

Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas

✍ Karolina Partheen; Kristina Levan; Lovisa Österberg; Ingela Claesson; Ghita Fall 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 369 KB

## Abstract The mortality rate for patients with ovarian carcinomas is high and the available prognostic factors are insufficient. The use of biomarkers may contribute to better prediction and survival for these patients. We aimed to study the gene and protein expressions for 7 potential biomarkers